Trinity Biotech Plc (TRIB)

Trinity Biotech Stock Analysis & Ratings

TRIB Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.86 - $3.74
Previous Close$1.18
Average Volume (3M)522.24K
Market Cap$24.66M
P/E Ratio5.5
Next EarningsJul 21, 2022
EPS ForecastN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score6
EPS (TTM)0.21

Trinity Biotech News

Currently, no data available
Please return soon. This page is being updated.




P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Trinity Biotech’s price range in the past 12 months?
Trinity Biotech lowest stock price was $0.86 and its highest was $3.74 in the past 12 months.
    What is Trinity Biotech’s market cap?
    Trinity Biotech’s market cap is $24.66M.
      What is Trinity Biotech’s price target?
      Currently, no data Available
      What do analysts say about Trinity Biotech?
      Not enough analysts have published a price target to provide an average price target.
      When is Trinity Biotech’s upcoming earnings report date?
      Trinity Biotech’s upcoming earnings report date is Jul 21, 2022 which is in 65 days.
        How were Trinity Biotech’s earnings last quarter?
        Currently, no data Available
        Is Trinity Biotech overvalued?
        According to Wall Street analysts Trinity Biotech’s price is currently Overvalued.
          Does Trinity Biotech pay dividends?
          Trinity Biotech pays a Annually dividend of $0.22 which represents an annual dividend yield of N/A. Trinity Biotech’s last Annually dividend payment was on Jul 01, 2015. Trinity Biotech’s upcoming ex-dividend date is Jun 05, 2015
            What is Trinity Biotech’s EPS estimate?
            Trinity Biotech’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Trinity Biotech have?
            Trinity Biotech has 20,900,000 shares outstanding.
              What happened to Trinity Biotech’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Trinity Biotech?
              Among the largest hedge funds holding Trinity Biotech’s share is Stonehill Capital Management Llc. It holds Trinity Biotech’s shares valued at 2M.


                Trinity Biotech Stock Analysis

                Smart Score
                Price Target
                No data currently available
                The Trinity Biotech stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Trinity Biotech Plc

                Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

                Similar Stocks
                Price & Change
                Bio-Rad Laboratories
                Orasure Technologies
                Thermo Fisher
                Roche Holding
                Chembio Diagnostics

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis